China Biologic Products to Present at UBS Global Life Sciences Conference on September 19

PR Newswire
TAI'AN, China
Sep 16, 2011

TAI'AN, China, Sept. 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at the UBS Global Life Sciences Conference in New York on September 19.

Mr. Tristan Kuo, China Biologic's Chief Financial Officer, will present at the conference on Monday, September 19, 2011 at 2:00 p.m. in the Grand Hyatt New York, 109 East 42nd Street at Grand Central Terminal, New York, NY.

Institutional investors interested in meeting with Mr. Kuo during the conference should please contact their UBS sales representative.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd., and Guiyang Dalin Biologic Technologies Co., Ltd., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical companies in China.

China Biologic is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website at www.chinabiologic.com for additional information.


                                    Company Contact

                                  Mr. Y. Tristan Kuo
                                Chief Financial Officer
                             China Biologic Products, Inc.
                                 Tel: +86 53 8620 2206
                              Email: IR@chinabiologic.com
                                 www.chinabiologic.com

SOURCE China Biologic Products, Inc.

SOURCE: China Biologic Products, Inc.

China Biologic Products to Present at UBS Global Life Sciences Conference on September 19

PR Newswire

TAI'AN, China, Sept. 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at the UBS Global Life Sciences Conference in New York on September 19.

Mr. Tristan Kuo, China Biologic's Chief Financial Officer, will present at the conference on Monday, September 19, 2011 at 2:00 p.m. in the Grand Hyatt New York, 109 East 42nd Street at Grand Central Terminal, New York, NY.

Institutional investors interested in meeting with Mr. Kuo during the conference should please contact their UBS sales representative.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd., and Guiyang Dalin Biologic Technologies Co., Ltd., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical companies in China.

China Biologic is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website at www.chinabiologic.com for additional information.

Company Contact


Mr. Y. Tristan Kuo

Chief Financial Officer

China Biologic Products, Inc.

Tel: +86 53 8620 2206

Email: IR@chinabiologic.com

www.chinabiologic.com



SOURCE China Biologic Products, Inc.

Web Site: http://www.chinabiologic.com


print email rss
© 2014 China Biologic Products, Inc. All Rights Reserved.